Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 11, 2019
American Health Packaging is voluntarily recalling eight lots of Ranitidine Syrup 150 mg/10 mL Liquid Unit Dose Cups to the consumer level.
read more
Monday, November 11, 2019
Samsung Biologics announced the signing of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830.
read more
Tuesday, November 12, 2019
Alkermes announced the receipt of a $150 million milestone payment from Biogen triggered by the recent FDA approval of VUMERITY.
read more
Wednesday, November 13, 2019
Amneal Pharmaceuticals is voluntarily recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL to the consumer level.
read more
Wednesday, November 20, 2019
Akcea and Ionis announced the closing of the exclusive licensing agreement with Pfizer for AKCEA-ANGPTL3-LRx.
read more
Friday, November 22, 2019
Heraeus Pharmaceutical Ingredients has expanded its capacity for Platinum-based highly potent active pharmaceutical ingredients with an additional production line built at the company’s headquarters in Hanau, Germany.
read more
Friday, December 06, 2019
The FDA has been investigating the presence of genotoxic impurities, called nitrosamines, in some types of drugs.
read more
Friday, December 06, 2019
ChromaDex has announced the expansion of its partnership with Matakana Health (MHL) until early 2023, which will now include Australia in its territory.
read more
Tuesday, December 10, 2019
Catalent has completed clinical production of Bridge Therapeutics’ opioid addiction development therapeutic product, BT-219.
read more
Monday, December 16, 2019
Sanofi Pasteur has entered into an agreement with the U.S. HHS to increase the company's domestic pandemic influenza vaccine production capabilities.
read more
Tuesday, December 17, 2019
Recipharm, the CDMO, has partnered with biotechnology company Aptahem, for the formulation of Apta-1 drug candidate.
read more
Wednesday, December 18, 2019
Civica Rx and Hikma Pharmaceuticals announced imminent shipments of Heparin Sodium Injection, USP, and seven other essential injectable medicines.
read more
Thursday, December 19, 2019
WindMIL has entered into a research collaboration with Bristol-Myers Squibb to evaluate MILs in combination with Opdivo in patients with locally advanced unresectable or metastatic NSCLC.
read more
Monday, December 23, 2019
Lacutamab will not be administered to new patients in the TELLOMAK trial until additional feedback is received from the respective regulatory agencies overseeing our clinical trial.
read more
Monday, December 23, 2019
Lannett has received approvals from the FDA of its ANDAs for Butalbital, Acetaminophen and Caffeine Capsules.
read more